Waiting for results of a CT scan after a cancer diagnosis is agonizing, as I anxiously await news on whether my disease has ...
Ten days of subcutaneous Dacogen resulted in responses among a third of patients with myelofibrosis. Among patients with ...
Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.